Clinical Trials Browser

Terminated × Carcinoma, Hepatocellular × Docetaxel × Clear all

NCT00532441 2016-02-12

Erlotinib in Combination With Docetaxel in Advanced Hepatocellular and Biliary Tract Carcinomas

Phase 2 Terminated

25 enrolled 13 charts

Gastrointestinal

Carcinoma, Hepatocellular